Expansion of <i><scp>BCR</scp>/<scp>ABL</scp>1</i><sup>+</sup> cells requires <scp>PAK</scp>2 but not <scp>PAK</scp>1
Leo Edlinger(University of Veterinary Medicine Vienna), Andrea Hoelbl‐Kovacic(University of Veterinary Medicine Vienna), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Christine Brostjan(Medical University of Vienna), Gregor Hoermann(University of Freiburg), Georg Greiner(Ludwig Boltzmann Institute Applied Diagnostics), Ingeborg Menzl(University of Veterinary Medicine Vienna), Angelika Berger‐Becvar(University of Veterinary Medicine Vienna), Andreas Spittler(Medical University of Vienna), Wael Al Zoughbi(Medical University of Graz), Lars Gille(University of Vienna), Gerald Höefler(Medical University of Graz), Eva Grundschober(University of Veterinary Medicine Vienna), Veronika Sexl(University of Veterinary Medicine Vienna), Richard Moriggl(University of Salzburg)
Cited by 17
Related Papers
Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice
|Science|2018|422
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
|Annals of Oncology|2013|403
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
|Nature Medicine|2022|395
Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure–activity relationship
|Biochemical Pharmacology|2005|303